Page 132 - MemoriaES-Eng
P. 132
RESEARCH GROUPS
ó
é
íí
PROGRAMME:
Group 26
Pneumonia
é
Group Members
Lead Researcher
STAFF MEMBERS
Prez Trallero, Emilio
Esnal Lasarte, Olatz
Moreiro Olondris, Esther
Contact:
Tamayo Oya, Esther
Servicio de Microbiología. Hospital Donostia
ASSOCIATED MEMBERS
Po Dr. Beguiristain, s/n. 20080 San Sebastián, Guipúzcoa
Phone: (+34) 94 300 71 53 · E.mail: [email protected]
Alonso Asencor, Marta
Cilla Eguiluz, Carlos Gustavo
Ercibengoa Arana, Mara
Marimn Ortiz de Zarate, Jos Ma
Main lines of research
Montes Ros, Milagrosa
Vicente Anza, Diego RESPIRATORY INFECTION:
Villar Vidal, Mara
Main objective: to study the epidemiology of respiratory infections.
• Streptococcus pneumoniae infection.
- Pneumococcal invasive infection in paediatric and adult populations: inci-
dence, serotypes and genotypes.
- Non-invasive pneumococcal infection: otitis media and conjunctivitis. Sero-
types and genotypes. Antibiotic resistance.
- Studies on vaccines. Impact of the 13 -valent conjugate vaccine. Compari-
son with the 7-valent vaccine. Influence of childhood vaccination with the new
13-valent vaccine on invasive infection and nasopharyngeal carriage in the first
years of life.
13
20
- Design of new pneumococcal typing techniques.
T
R
- Determine the evolution of S. pneumoniae antibiotic resistance over time: PO
new serotypes causing infection and genetic resistance determinants; influence E
L R
of antibiotic consumption in resistance; spread of multi-resistant clones after A
NU
the introduction of conjugate vaccines.
N
- To confirm the replacement of the “resistant serotypes” as a result of the A
/
commercialization of 13-valent conjugate vaccine in 2010.
ES
ER
- Influence of childhood vaccination on antibiotic resistance in adults. B
CI
• Streptococcus pyogenes infection.
132
- Incidence and characterization of strains causing invasive disease.